# RENEO PHARMACEUTICALS INC (RPHM)

> Institutional ownership reported to the SEC as of Q4 2025, from Form 13F filings. Source: https://holderbook.com/stocks/RPHM/

- Reporting holders: 1
- Reported value: $1.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Torren Management, LLC](https://holderbook.com/funds/2096203-torren-management-llc/) | $1.5K | 504 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2025 | 1 | $1.5K |
| Q3 2024 | 48 | $44.8M |
| Q2 2024 | 64 | $38.5M |
| Q1 2024 | 63 | $42.3M |
| Q4 2023 | 73 | $41.1M |
| Q3 2023 | 58 | $189.0M |
| Q2 2023 | 52 | $168.9M |
| Q1 2023 | 35 | $102.0M |
| Q4 2022 | 32 | $38.4M |
| Q3 2022 | 32 | $55.1M |
| Q2 2022 | 30 | $43.3M |
| Q1 2022 | 41 | $50.8M |